Pages that link to "Q37979969"

The following pages link to Multiple sclerosis: neuroprotective alliance of estrogen-progesterone and gender (Q37979969):

Displaying 23 items.

• Embracing failure: What the Phase III progesterone studies can teach about TBI clinical trials (Q24273391) (← links)
• The structural biology of oestrogen metabolism (Q27009283) (← links)
• Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects. (Q30355283) (← links)
• Subcutaneous interferon β-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS study (Q31141962) (← links)
• Sex-dependent treatment of chronic EAE with partial MHC class II constructs (Q33645392) (← links)
• Safety of hormonal replacement therapy and oral contraceptives in systemic lupus erythematosus: a systematic review and meta-analysis. (Q34066226) (← links)
• Integrating multiple oestrogen receptor alpha ChIP studies: overlap with disease susceptibility regions, DNase I hypersensitivity peaks and gene expression (Q34493813) (← links)
• Effect of intrahippocampal administration of vitamin C and progesterone on learning in a model of multiple sclerosis in rats (Q35155319) (← links)
• Endogenous progesterone levels and frontotemporal dementia: modulation of TDP-43 and Tau levels in vitro and treatment of the A315T TARDBP mouse model. (Q37137776) (← links)
• The role of EGFR and ErbB family related proteins in the oligodendrocyte specification in germinal niches of the adult mammalian brain. (Q37397740) (← links)
• 17β-Estradiol Promotes Schwann Cell Proliferation and Differentiation, Accelerating Early Remyelination in a Mouse Peripheral Nerve Injury Model. (Q37410763) (← links)
• Pharmacological approaches to intervention in hypomyelinating and demyelinating white matter pathology (Q38538932) (← links)
• Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis (Q39091396) (← links)
• The promyelinating properties of androstenediol in gliotoxin-induced demyelination in rat corpus callosum. (Q41197337) (← links)
• Hepatic expression of metallothionein I/II, glycoprotein 96, IL-6, and TGF- β in rat strains with different susceptibilities to experimental autoimmune encephalomyelitis. (Q41875308) (← links)
• Sex differences in resting-state functional connectivity in multiple sclerosis. (Q43647987) (← links)
• The contribution of oligodendrocytes and oligodendrocyte progenitor cells to central nervous system repair in multiple sclerosis: perspectives for remyelination therapeutic strategies (Q47870855) (← links)
• Gender differences in multiple sclerosis: induction of estrogen signaling in male and progesterone signaling in female lesions. (Q51168522) (← links)
• Effects of Lipopolysaccharide and Progesterone Exposures on Embryonic Cerebral Cortex Development in Mice. (Q52145698) (← links)
• 17β-Estradiol Enhances Schwann Cell Differentiation via the ERβ-ERK1/2 Signaling Pathway and Promotes Remyelination in Injured Sciatic Nerves (Q57816966) (← links)
• A novel neurotherapeutic for multiple sclerosis, ischemic injury, methamphetamine addiction, and traumatic brain injury (Q61445020) (← links)
• 17β-estradiol delays 6-OHDA-induced apoptosis by acting on Nur77 translocation from the nucleus to the cytoplasm (Q86846162) (← links)
• Oestrogen treatment of experimental autoimmune encephalomyelitis requires 17β-oestradiol-receptor-positive B cells that up-regulate PD-1 on CD4+ Foxp3+ regulatory T cells (Q87413079) (← links)